The abstract is read at the publisher; the summary is JClub's.
Hepatocyte-specific loss of ATM in a preclinical MASLD model significantly worsens liver damage and fibrosis by triggering mitochondrial hypermetabolism and a bioenergetic crisis.
- Why it matters: MASLD and its progressive fibrosing form, MASH, are common and worsening, but the molecular drivers of progression are not well defined.
- What they did: The study links replication stress across all human MASLD stages and an ATM-mediated DNA damage response signature to advanced, fibrosing MASH, then tests ATM function in a preclinical MASLD model.
- The result: ATM-deficient MASLD hepatocytes show increased oxygen consumption, proton leak, ROS production, mitophagy, and severe nucleotide pool imbalance with energy deficit and toxic lipid accumulation, implying ATM restrains mitochondrial dysfunction during progression.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.